The National Institute for Health and Care Excellence (NICE) confirmed that semaglutide increases insulin secretion by binding and activating the GLP-1 receptor (glucagon-like peptide-1)....
The joint research project aims to better understand the risks associated with diagnosing type 1 or type 2 diabetes
The Institute and School of Actuaries...